CA2079485C - Chelator compositions comprising oxime compounds - Google Patents

Chelator compositions comprising oxime compounds

Info

Publication number
CA2079485C
CA2079485C CA002079485A CA2079485A CA2079485C CA 2079485 C CA2079485 C CA 2079485C CA 002079485 A CA002079485 A CA 002079485A CA 2079485 A CA2079485 A CA 2079485A CA 2079485 C CA2079485 C CA 2079485C
Authority
CA
Canada
Prior art keywords
alkyl
composition
membered aryl
group
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002079485A
Other languages
English (en)
French (fr)
Other versions
CA2079485A1 (en
Inventor
Rodney Dean Bush
Donald Lynn Bissett
Ranjit Chatterjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CA2079485A1 publication Critical patent/CA2079485A1/en
Application granted granted Critical
Publication of CA2079485C publication Critical patent/CA2079485C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002079485A 1990-04-26 1991-04-09 Chelator compositions comprising oxime compounds Expired - Fee Related CA2079485C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US51499890A 1990-04-26 1990-04-26
US514,998 1990-04-26
US65784791A 1991-02-25 1991-02-25
US657,847 1991-02-25
PCT/US1991/002398 WO1991016034A1 (en) 1990-04-26 1991-04-09 Chelator compositions comprising oxime compounds

Publications (2)

Publication Number Publication Date
CA2079485A1 CA2079485A1 (en) 1991-10-27
CA2079485C true CA2079485C (en) 1999-05-11

Family

ID=27058372

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002079485A Expired - Fee Related CA2079485C (en) 1990-04-26 1991-04-09 Chelator compositions comprising oxime compounds

Country Status (8)

Country Link
US (1) US5364617A (de)
EP (1) EP0611301B1 (de)
AT (1) ATE242625T1 (de)
AU (1) AU662101B2 (de)
CA (1) CA2079485C (de)
DE (1) DE69133277T2 (de)
ES (1) ES2199214T3 (de)
WO (1) WO1991016034A1 (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439954A (en) * 1991-10-11 1995-08-08 The Procter & Gamble Company Substituted phenyl-1,3-diketones as protectants against skin damage
US5686436A (en) 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
WO1995001157A1 (en) * 1993-06-29 1995-01-12 The Procter & Gamble Company Use of hydroxyphenyl oximes as chelating photoprotectants
CA2186867C (en) * 1994-04-08 2000-12-12 Donald L. Bissett Methods of using iron chelating compounds to reduce free radical damage in mammals
US5922758A (en) * 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage
US5739156A (en) * 1994-09-21 1998-04-14 The Procter & Gamble Company Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells
US5624664A (en) * 1995-01-30 1997-04-29 Lambrechts; John Skin conditioning composition and softgel filled therewith
CA2223385A1 (en) * 1995-06-07 1996-12-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stabilized steroid compositions
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US5829449A (en) * 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
CN1376049A (zh) * 1999-08-24 2002-10-23 宝洁公司 通过局部施用含肟化合物的组合物增白角质组织的方法
DE10031703A1 (de) * 2000-06-29 2002-01-10 Beiersdorf Ag Verwendung von Calcium freisetzenden oder bindenden Substanzen zur gezielten Schächung oder Stärkung der Barrierefunktion der Haut
AU2002220121A1 (en) * 2000-11-28 2002-06-11 Lorillard Licensing Company, Llc A smoking article including a selective carbon monoxide pump
US6481442B1 (en) 2000-11-28 2002-11-19 Lorillard Licensing Company, Llc Smoking article including a filter for selectively removing carbonyls
US6677294B2 (en) 2000-11-29 2004-01-13 The Procter & Gamble Company Cleansing compositions
ITPI20010014A1 (it) * 2001-03-05 2002-09-05 Ivo Pera Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
US20050281766A1 (en) * 2002-03-11 2005-12-22 Avon Products, Inc. Method of improving the aesthetic appearance of epithelia
US7235249B2 (en) 2002-03-28 2007-06-26 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
US7098189B2 (en) 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
JP4058073B2 (ja) 2002-12-20 2008-03-05 ザ プロクター アンド ギャンブル カンパニー 布状のパーソナルケア用品
US20050003024A1 (en) 2003-03-04 2005-01-06 The Procter & Gamble Company Regulation of mammalian hair growth
US20040175347A1 (en) 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
EP1686957B1 (de) 2003-11-17 2012-03-07 Sederma Zusammensetzungen mit einer kombination von tetrapeptiden und tripeptiden
US20070191368A1 (en) * 2004-03-23 2007-08-16 Bissett Donald L Inhibition of tissue damage to skin from radiation treatment therapy
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
FR2880802B1 (fr) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
US8147853B2 (en) 2005-02-15 2012-04-03 The Procter & Gamble Company Personal care compositions containing hydrophobically modified non-platelet particles
FR2890310B1 (fr) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
US7485609B2 (en) * 2005-09-29 2009-02-03 Kimberly-Clark Worldwide, Inc. Encapsulated liquid cleanser
US7614812B2 (en) 2005-09-29 2009-11-10 Kimberly-Clark Worldwide, Inc. Wiper with encapsulated agent
ES2661728T3 (es) 2005-10-03 2018-04-03 Pinksky, Mark A. Composiciones y métodos para el cuidado mejorado de la piel
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
CN100475189C (zh) 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
EP2659896A3 (de) 2007-09-28 2014-06-11 Johnson & Johnson Consumer Companies Inc. Stromerzeugende Teilchen und Verwendung davon
US20090187060A1 (en) * 2008-01-22 2009-07-23 E-Z-Em, Inc. Method and Formulation for Neutralizing Toxic Chemicals and Materials
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
WO2010082177A2 (en) 2009-01-16 2010-07-22 Sederma New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
US8859235B2 (en) 2009-08-14 2014-10-14 Basf Se Methods in cell cultures, and related inventions, employing certain additives
MX2012003820A (es) 2009-10-06 2012-05-17 Basf Se Estabilizacion de productos para el hogar, para el cuidado corporal y alimenticios al usar extractos de planta que contienen benzotropolona y/o derivados de benzotropolona relacionados.
US20110166370A1 (en) 2010-01-12 2011-07-07 Charles Winston Saunders Scattered Branched-Chain Fatty Acids And Biological Production Thereof
WO2011156672A2 (en) 2010-06-11 2011-12-15 The Procter & Gamble Company Compositions for treating skin
WO2012009523A2 (en) 2010-07-15 2012-01-19 The Procter & Gamble Company A personal care composition comprising a near-terminal branched compound
US20120172281A1 (en) 2010-07-15 2012-07-05 Jeffrey John Scheibel Detergent compositions comprising microbially produced fatty alcohols and derivatives thereof
US20120021014A1 (en) 2010-07-23 2012-01-26 Jeannette Chantalat Corrosion current-generating metal particulates and use thereof
DE102010045890A1 (de) * 2010-09-17 2012-03-22 Merck Patent Gmbh 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung
WO2013091894A2 (en) 2011-12-21 2013-06-27 Flavin Dana Topical compositions
US8895041B2 (en) 2012-03-23 2014-11-25 The Procter & Gamble Company Compositions for delivering perfume to the skin
CA2902279C (en) 2013-03-05 2019-05-28 The Procter & Gamble Company Mixed sugar amine or sugar amide surfactant compositions
EP2857004B1 (de) 2013-10-07 2018-07-04 The Procter and Gamble Company Haarglättungsverfahren mit reduzierenden Zuckern
CN106715463B (zh) 2013-12-10 2020-10-16 苏塞克斯研究实验室 糖化肽组合物及其用途
EP3082735B1 (de) 2013-12-19 2018-05-02 The Procter and Gamble Company Formung von keratinfasern mit oxoethansäure und/oder derivaten davon
JP6334710B2 (ja) 2013-12-19 2018-05-30 ザ プロクター アンド ギャンブル カンパニー アミン又はジアミンを使用したケラチン繊維の整形
WO2015094759A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using an active agent comprising at least two functional groups selected from: -c(oh)- and -c(=o)oh
CN105828786B (zh) 2013-12-19 2020-07-07 宝洁公司 使用包含选自-c(＝o)-、-c(＝o)-h和-c(＝o)-o-的官能团的an活性剂使角蛋白纤维成形
MX357743B (es) 2013-12-19 2018-07-23 Procter & Gamble Formacion de fibras de queratina con 2-hidroxipropano-1,2,3-acido tricarboxilico y/o 1,2,3,4-acido butanetetracarboxilico.
MX361100B (es) 2013-12-19 2018-11-27 Procter & Gamble Modelado de fibras de queratina mediante el uso de un azucar.
WO2015094760A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using carbonate ester
MX376963B (es) 2013-12-19 2025-03-07 Procter & Gamble Modelado de fibras de queratina mediante el uso de éster de carbonato.
US20150352034A1 (en) 2014-06-08 2015-12-10 Solazyme, Inc. Personal Care Products Containing Microalgae or Extracts Thereof
US20160000682A1 (en) 2014-07-02 2016-01-07 Geoffrey Brooks Consultants Llc Peptide-Based Compositions and Methods of Use
MX365260B (es) 2014-11-10 2019-05-27 Procter & Gamble Composiciones para el cuidado personal.
EP3217948B1 (de) 2014-11-10 2020-09-16 The Procter and Gamble Company Körperpflegezusammensetzungen mit zwei vorteilsphasen
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
US20160128927A1 (en) 2014-11-10 2016-05-12 The Procter & Gamble Company Personal Care Compositions With Two Benefit Phases
EP3297731A1 (de) 2014-12-19 2018-03-28 The Procter and Gamble Company Formung von keratinfasern mit arabinose und ethylencarbonat
CN107106450B (zh) 2014-12-19 2020-12-01 宝洁公司 利用阿拉伯糖和碳酸亚乙酯使角蛋白纤维成形
EP3297730A1 (de) 2014-12-19 2018-03-28 The Procter and Gamble Company Verfahren zur formgebung von keratinischen fasern
US10945931B2 (en) 2015-06-18 2021-03-16 The Procter And Gamble Company Shaping keratin fibres using dialdehyde compounds
JP6615916B2 (ja) 2015-06-18 2019-12-04 ザ プロクター アンド ギャンブル カンパニー ２−オキサゾリジノン化合物を使用したケラチン繊維の整形
CN105267066B (zh) 2015-10-08 2019-06-11 知识产权全资有限公司 用于处理头发的方法及其试剂盒
CN105902404A (zh) 2016-06-14 2016-08-31 知识产权全资有限公司 强发成分以及强发的方法
CN105902403A (zh) 2016-05-19 2016-08-31 知识产权全资有限公司 强发成分以及强发的方法
CN106265109A (zh) 2016-08-22 2017-01-04 知识产权全资有限公司 强发成分以及强发并使头发具有极佳手感的方法
WO2019079405A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company AEROSOL FOAMING CLEANSER FOR THE SKIN
CN111212625B (zh) 2017-10-20 2023-05-23 宝洁公司 气溶胶泡沫洁肤剂
CN111432892B (zh) 2017-12-08 2023-08-29 宝洁公司 筛选温和洁肤剂的方法
BE1026073B1 (nl) * 2018-03-05 2019-10-07 Purna Pharmaceuticals Nv Verbeterde werkwijze voor het maken van een farmaceutische emulsie
US10369396B1 (en) 2018-11-09 2019-08-06 Battelle Memorial Institute Assembly for decontaminating and method of manufacturing the assembly
WO2020112486A1 (en) 2018-11-29 2020-06-04 The Procter & Gamble Company Methods for screening personal care products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058886A (en) * 1957-08-20 1962-10-16 Dyk & Company Inc Van Skin-protecting sunscreening process
US3836528A (en) * 1968-07-23 1974-09-17 Dainippon Pharmaceutical Co Alpha-(5-nitro-2-furyl)nitrones
CA1138474A (en) * 1978-03-08 1982-12-28 Riekert Kok Process for the preparation of a 1,2-dioxime
US4401649A (en) * 1981-07-20 1983-08-30 Polaroid Corporation Sunscreen method
DE3856315T2 (de) * 1987-10-22 1999-10-14 The Procter & Gamble Co. Chelatbildner enthaltende Lichtschutzmittel
US5155110A (en) * 1987-10-27 1992-10-13 Warner-Lambert Company Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition

Also Published As

Publication number Publication date
EP0611301A1 (de) 1994-08-24
ATE242625T1 (de) 2003-06-15
AU662101B2 (en) 1995-08-24
DE69133277T2 (de) 2004-04-08
WO1991016034A1 (en) 1991-10-31
ES2199214T3 (es) 2004-02-16
CA2079485A1 (en) 1991-10-27
AU7756591A (en) 1991-11-11
EP0611301B1 (de) 2003-06-11
EP0611301A4 (de) 1993-03-01
DE69133277D1 (de) 2003-07-17
US5364617A (en) 1994-11-15

Similar Documents

Publication Publication Date Title
CA2079485C (en) Chelator compositions comprising oxime compounds
US5462963A (en) Chelator compositions comprising α-diamine compounds
EP0496433B1 (de) Chelatbildner enthaltende Lichtschutzmittel
US5709847A (en) Compositions comprising a radical scavenging compound and an anti-inflammatory agent
CA2192665C (en) Methods of lightening hyperpigmented regions in mammalian skin
US5849728A (en) Desquamation compositions
US4847072A (en) Photoprotection compositions comprising tocopherol sorbate
US4847071A (en) Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US5439954A (en) Substituted phenyl-1,3-diketones as protectants against skin damage
US5296500A (en) Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
EP0601088B1 (de) N-acetyl-l-cystein und derivate zur kontrolle von hautfalten und/oder hautatrophie
NZ226664A (en) Sunscreen composition containing sorbohydroxamic acid
US5118707A (en) Compositions for regulating skin wrinkles comprising a benzofuran derivative
WO1995001157A1 (en) Use of hydroxyphenyl oximes as chelating photoprotectants
US5492690A (en) Benzoylacetate esters as non-sensitizing chelating photo-protectants
AU738434B2 (en) Topical compositions for regulating the oily/shiny appearance of skin
HK1006419B (en) Use of n-acetyl-l-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed